NovoCure Limited (NVCR)

NovoCure Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	149.62	163.77	240.82	115.33	208.8	234.67
Short-Term Investments	761.9	796.11	669.8	854.1	728.9	607.9
Cash & Short-Term Investments	911.53	959.87	910.62	969.43	937.7	842.58
Cash Growth	-4.17%	5.41%	-6.07%	3.38%	11.29%	158.39%
Accounts Receivable	89.92	74.23	61.22	86.26	93.57	96.7
Other Receivables	39.14	3.33	5.26	12.39	8.42	13.36
Receivables	129.05	77.55	66.48	98.65	101.99	110.06
Inventory	40.21	35.09	38.15	29.38	24.43	27.42
Prepaid Expenses	-	7.32	6.85	6.42	4.76	4.12
Restricted Cash	2.51	2.33	1.74	0.51	0.81	11.5
Other Current Assets	-	24.41	10.56	7.15	3.84	3.77
Total Current Assets	1,083	1,107	1,034	1,112	1,074	999.44
Property, Plant & Equipment	147.01	119.59	97.7	68.96	53.88	41.63
Other Long-Term Assets	15.56	14.62	14.02	11.16	12.09	10.91
Total Assets	1,246	1,241	1,146	1,192	1,139	1,052
Accounts Payable	103.68	105.09	94.39	85.2	72.6	53.65
Accrued Expenses	-	70.98	60.18	49.44	45.39	35.66
Current Portion of Long-Term Debt	559.79	558.16	-	-	-	-
Current Portion of Leases	-	7.91	-	-	-	-
Current Unearned Revenue	-	14.23	16.22	18.03	17.76	17.77
Other Current Liabilities	86.17	0.01	8.32	6.11	6.85	6.54
Total Current Liabilities	749.63	756.38	179.12	158.78	142.6	113.61
Long-Term Debt	97.61	97.3	568.82	565.58	562.23	429.95
Long-Term Leases	42.85	19.97	27.42	18.76	13	14.29
Long-Term Unearned Revenue	-	-	-	2.88	6.48	12.14
Other Long-Term Liabilities	0.02	0.02	0.02	0.08	0.15	0.3
Total Liabilities	896.43	880.61	783.63	750.48	729	575.46
Additional Paid-In Capital	1,583	1,520	1,353	1,222	1,100	1,111
Retained Earnings	-1,229	-1,154	-985.5	-778.46	-685.93	-631.08
Comprehensive Income & Other	-5.11	-5.5	-5.47	-2.43	-3.17	-3.83
Shareholders' Equity	349.44	360.18	362.5	441.17	410.49	476.53
Total Liabilities & Equity	1,246	1,241	1,146	1,192	1,139	1,052
Total Debt	700.25	683.34	596.24	584.34	575.23	444.24
Net Cash (Debt)	211.27	276.53	314.37	385.08	362.48	398.34
Net Cash Growth	-23.45%	-12.04%	-18.36%	6.24%	-9.00%	145.19%
Net Cash Per Share	1.93	2.56	2.95	3.68	3.50	3.66
Filing Date Shares Outstanding	111.8	109.92	107.09	105.46	104.42	102.41
Total Common Shares Outstanding	111.8	108.52	107.08	105.05	103.97	102.33
Working Capital	333.67	350.2	855.29	952.75	930.92	885.83
Book Value Per Share	3.13	3.32	3.39	4.20	3.95	4.66
Tangible Book Value	349.44	360.18	362.5	441.17	410.49	476.53
Tangible Book Value Per Share	3.13	3.32	3.39	4.20	3.95	4.66
Land	-	34.53	24.7	15.99	11.16	-
Machinery	-	63.31	43.05	30.94	26.56	23.32
Leasehold Improvements	-	12.13	11.7	9.35	7.08	6.5

Updated Jul 24, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q